Table 1.
Demographic and clinical data for Kawasaki disease cases
| Case no. | Age (months) | Duration of illness at death (weeks) | Sex (M/F) | Ethnicity | Treatment | Cause of death |
|---|---|---|---|---|---|---|
| 1 | 3·5 | 3·5 | M | C | IVIG, ASA, steroid | Small intestine infarction, mesenteric artery aneurysm |
| 2 | 4 | 5 | M | U | IVIG, ASA, steroid | Myocardial infarction |
| 3 | 4 | 3 | M | C | IVIG, ASA | Myocardial infarction |
| 4 | 4 | 4 | M | H | None | Myocardial infarction |
| 5 | 4 | 4 | M | C | IVIG, steroid, cyclophosphamide, infliximab, anakinra | Myocardial infarction |
| 6 | 4 | 3·5 | M | C | None | Myocardial infarction |
| 7 | 4 | 8 | F | C | IVIG, ASA, steroid, methotrexate | Myocardial infarction |
| 8 | 4·5 | 4 | M | H | IVIG, ASA, infliximab, steroid | Ruptured right common iliac artery aneurysm |
| 9 | 6 | 6·5 | M | A | IVIG, ASA, steroid, cyclophosphamide | Myocardial infarction |
| 10 | 6 | 4·5 | M | C | Steroid | Myocardial infarction |
| 11 | 10 | 4 | F | AA | ASA, dipyridamole | Myocardial infarction |
| 12 | 11 | 2·5 | M | C | None | Ruptured coronary artery aneurysm |
A = Asian; AA = African American; C = Caucasian; H = Hispanic; U = unknown; IVIG = intravenous immunoglobulin; ASA = acetylsalicylic acid.